ATM deficiency is associated with sensitivity to PARP1- and ATR inhibitors in lung adenocarcinoma

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Lung Adenocarcinoma 100%
• Cisplatin 33%
• Mouse Model 33%
• Etoposide 33%
• DNA Topoisomerase (ATP Hydrolysing) 33%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor 33%
• Genetic Risk 33%

Medicine and Dentistry

• Neoplasm 100%
• Lung Adenocarcinoma 100%
• Protein P53 33%
• Olaparib 33%
• ATM Protein 33%
• Cisplatin 33%
• DNA Topoisomerase (ATP Hydrolysing) 33%
• DNA Damage Response 33%

Biochemistry, Genetics and Molecular Biology

• Mouse Model 33%
• Poly ADP Ribose Polymerase 33%
• Kinase 33%
• Phosphotransferase 33%
• Genetic Risk 33%
• P53 33%
• DNA Gyrase 33%
• Cisplatin 33%